Journal of the Formosan Medical Association
Volume 108, Issue 7 , Pages 548-553 , July 2009

Combination of Low-dose Nalbuphine and Morphine in Patient-controlled Analgesia Decreases Incidence of Opioid-related Side Effects

  • Yu-Chang Yeh

      Affiliations

    • Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Tzu-Fu Lin

      Affiliations

    • Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Hung-Chi Chang

      Affiliations

    • Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Wing-Sum Chan

      Affiliations

    • Department of Anesthesiology, Far-Eastern Memorial Hospital, Taipei, Taiwan
    • ,
  • Yong-Ping Wang

      Affiliations

    • Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Chen-Jung Lin

      Affiliations

    • Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Wei-Zen Sun

      Affiliations

    • Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Wei-Zen Sun, Department of Anesthesiology, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 2 September 2008 ,Revised 20 November 2008 ,Accepted 8 January 2009.

References 

  1. Chen JC , Smith ER , Cahill M , et al.   The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine . Life Sci . 1993;52:389–396
  2. Pick CG , Paul D , Pasternak GW . Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice . J Pharmacol Exp Ther . 1992;262:1044–1050
  3. De Souza EB , Schmidt WK , Kuhar MJ . Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic . J Pharmacol Exp Ther . 1988;244:391–402
  4. Gunion MW , Marchionne AM , Anderson CTM . Use of the mixed agonist-antagonist nalbuphine in opioid based analgesia . Acute Pain . 2004;6:29–39
  5. Cepeda MS , Alvarez H , Morales O , et al.   Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects . Pain . 2004;107:41–46
  6. Yeh YC , Lin TF , Wang CH , et al.   Effect of combining ultralow-dose naloxone with morphine in intravenous patient-controlled analgesia: the cut-off ratio of naloxone to morphine for antiemesis after gynecologic surgery . J Formos Med Assoc . 2008;107:478–484
  7. Wang JJ , Ho ST , Tzeng JI . Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects . Reg Anesth Pain Med . 1998;23:479–484
  8. Kendrick WD , Woods AM , Daly MY , et al.   Naloxone versus nalbuphine infusion for prophylaxis of epidural morphine-induced pruritus . Anesth Analg . 1996;82:641–647
  9. Cohen SE , Ratner EF , Kreitzman TR , et al.   Nalbuphine is better than naloxone for treatment of side effects after epidural morphine . Anesth Analg . 1992;75:747–752
  10. Wang JJ , Ho ST , Hu OY . Comparison of intravenous nalbuphine infusion versus saline as an adjuvant for epidural morphine . Reg Anesth . 1996;21:214–218
  11. Wang JJ , Ho ST , Lee SC , et al.   The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: a dose-ranging study . Anesth Analg . 2000;91:1404–1407
  12. Lin TF , Yeh YC , Yen YH , et al.   Antiemetic and analgesicsparing effects of diphenhydramine added to morphine intravenous patient-controlled analgesia . Br J Anaesth . 2005;94:835–839
  13. Crain SM , Shen KF . Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability . Pain . 2000;84:121–131
  14. Shen KF , Crain SM . Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice . Brain Res . 1997;757:176–190
  15. Ueda H , Fukushima N , Kitao T , et al.   Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release . Neurosci Lett . 1986;65:247–252
  16. Charuluxananan S , Kyokong O , Somboonviboon W , et al.   Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery . Anesth Analg . 2003;96:1789–1793
  17. Somrat C , Oranuch K , Ketchada U , et al.   Optimal dose of nalbuphine for treatment of intrathecal-morphine induced pruritus after caesarean section . J Obstet Gynaecol Res . 1999;25:209–213
  18. Gear RW , Miaskowski C , Gordon NC , et al.   The kappa opioid nalbuphine produces gender-and dose-dependent analgesia and antianalgesia in patients with postoperative pain . Pain . 1999;83:339–345
  19. Gear RW , Miaskowski C , Gordon NC , et al.   Kappa-opioids produce significantly greater analgesia in women than in men . Nature Med . 1996;2:1248–1250

PII: S0929-6646(09)60372-7

doi: 10.1016/S0929-6646(09)60372-7

Journal of the Formosan Medical Association
Volume 108, Issue 7 , Pages 548-553 , July 2009

Article Tools